The effect of orally administered marbofloxacin on the pharmacokinetics of theophylline

被引:7
作者
Hirt, RA [1 ]
Teinfalt, M [1 ]
Dederichs, D [1 ]
van den Hoven, R [1 ]
机构
[1] Vet Univ Vienna, Clin Internal Med Small Anim & Horses, A-1210 Vienna, Austria
来源
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE | 2003年 / 50卷 / 05期
关键词
D O I
10.1046/j.1439-0442.2003.00538.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
As certain quinolones can interfere with the metabolism of theophylline by competitive inhibition of the hepatic microsomal cytochrome P450 system, concomitant use of these drugs with theophylline could result in theophylline toxicity. This study investigated the effect of orally administered marbofloxacin (2 and 5 mg/kg each once daily) on steady-state plasma pharmacokinetics of theophylline after concomitant oral administration of a sustained release theophylline preparation in dogs. Marbofloxacin caused some alteration in theophylline metabolism. A 2 mg/kg dose of marbofloxacin did not clearly result in an increased area under the concentration - time curve (AUC) or decreased clearance of theophylline, but at a dose of 5 mg/kg, a statistically significant increase in AUC and a decrease in the total clearance of theophylline was found. The 26% reduction in theophylline clearance is probably not clinically significant in healthy dogs, but for dogs with renal impairment, there might be a chance of theophylline accumulation when dosed concomitantly with marbofloxacin.
引用
收藏
页码:246 / 250
页数:5
相关论文
共 28 条
[1]   EFFECT OF OFLOXACIN ON THE PHARMACOKINETICS OF A SINGLE INTRAVENOUS THEOPHYLLINE DOSE [J].
ALTURK, WA ;
SHAHEEN, OM ;
OTHMAN, S ;
KHALAF, RM ;
AWIDI, AS .
THERAPEUTIC DRUG MONITORING, 1988, 10 (02) :160-163
[2]  
ANADON A, 1999, PHARM DRUG INT EAVPT
[3]   ENOXACIN - A POTENT INHIBITOR OF THEOPHYLLINE METABOLISM [J].
BECKMANN, J ;
ELSASSER, W ;
GUNDERTREMY, U ;
HERTRAMPF, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (03) :227-230
[4]   EFFECT OF NORFLOXACIN ON THEOPHYLLINE PHARMACOKINETICS AT STEADY-STATE [J].
BOWLES, SK ;
POPOVSKI, Z ;
RYBAK, MJ ;
BECKMAN, HB ;
EDWARDS, DJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) :510-512
[5]  
Cester CC, 1996, REV MED VET-TOULOUSE, V147, P703
[6]  
FUHR U, 1993, MOL PHARMACOL, V43, P191
[7]   METABOLISM OF THEOPHYLLINE BY CDNA-EXPRESSED HUMAN CYTOCHROMES P-450 [J].
HA, HR ;
CHEN, JZ ;
FREIBURGHAUS, AU ;
FOLLATH, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) :321-326
[8]   PROBABLE FATAL INTERACTION BETWEEN CIPROFLOXACIN AND THEOPHYLLINE [J].
HOLDEN, R .
BRITISH MEDICAL JOURNAL, 1988, 297 (6659) :1339-1339
[9]   ENROFLOXACIN THEOPHYLLINE INTERACTION - INFLUENCE OF ENROFLOXACIN ON THEOPHYLLINE STEADY-STATE PHARMACOKINETICS IN THE BEAGLE DOG [J].
INTORRE, L ;
MENGOZZI, G ;
MACCHERONI, M ;
BERTINI, S ;
SOLDANI, G .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1995, 18 (05) :352-356
[10]   BIOAVAILABILITY OF 4 SLOW-RELEASE THEOPHYLLINE FORMULATIONS IN THE BEAGLE DOG [J].
KORITZ, GD ;
MCKIERNAN, BC ;
NEFFDAVIS, CA ;
MUNSIFF, IJ .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1986, 9 (03) :293-302